LaaS is not a phase to apologize for. It is the *honest* business in this market. Periodic and Lila do the same thing in $300M-$550M costume. Replace "pivoting toward pre-screening" with "we run an AI-augmented contract R&D engine; pre-screening turns CRO economics into software-like margins."
The best-funded players admit off-stage what their pitch decks hide: there is no IP-owned product revenue. There is contract R&D, sold one-to-one, in different vocabularies.
Wildcat ($73M exit after $90-160M raised), Kebotix (17→4 staff pre-acquisition), AIONICS (-34.8% YoY), Mattiq (-42% YoY). Citrine 13yrs / $76M / no raise since Jan 2023 — the longest data-moat thesis is also the canary.
Don't apologize for the LaaS pivot. Frame as "AI-augmented contract R&D engine where pre-screening is the gross-margin lever."